Palisade Bio Inc. (PALI)
Palisade Bio Statistics
Share Statistics
Palisade Bio has 4.4M shares outstanding. The number of shares has increased by 369.53% in one year.
Shares Outstanding | 4.4M |
Shares Change (YoY) | 369.53% |
Shares Change (QoQ) | 58.95% |
Owned by Institutions (%) | 17.25% |
Shares Floating | 4.36M |
Failed to Deliver (FTD) Shares | 1.77K |
FTD / Avg. Volume | 0.3% |
Short Selling Information
The latest short interest is 43.11K, so 1.56% of the outstanding shares have been sold short.
Short Interest | 43.11K |
Short % of Shares Out | 1.56% |
Short % of Float | 1.57% |
Short Ratio (days to cover) | 0.29 |
Valuation Ratios
The PE ratio is -0.16 and the forward PE ratio is -0.39. Palisade Bio's PEG ratio is 0.
PE Ratio | -0.16 |
Forward PE | -0.39 |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | 0.31 |
P/FCF Ratio | -0.19 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Palisade Bio.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.01.
Current Ratio | 3.24 |
Quick Ratio | 3.24 |
Debt / Equity | 0.01 |
Debt / EBITDA | -0.01 |
Debt / FCF | -0.01 |
Interest Coverage | 1238.25 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-1.8M |
Employee Count | 8 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -88.7% in the last 52 weeks. The beta is 1.41, so Palisade Bio's price volatility has been higher than the market average.
Beta | 1.41 |
52-Week Price Change | -88.7% |
50-Day Moving Average | 1 |
200-Day Moving Average | 2.67 |
Relative Strength Index (RSI) | 30.97 |
Average Volume (20 Days) | 585.82K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -14.86M |
Net Income | -14.44M |
EBITDA | -14.86M |
EBIT | -14.45M |
Earnings Per Share (EPS) | -10.19 |
Balance Sheet
The company has 9.82M in cash and 90K in debt, giving a net cash position of 9.73M.
Cash & Cash Equivalents | 9.82M |
Total Debt | 90K |
Net Cash | 9.73M |
Retained Earnings | -135.94M |
Total Assets | 10.88M |
Working Capital | 7.26M |
Cash Flow
In the last 12 months, operating cash flow was -12.19M and capital expenditures 0, giving a free cash flow of -12.19M.
Operating Cash Flow | -12.19M |
Capital Expenditures | 0 |
Free Cash Flow | -12.19M |
FCF Per Share | -8.61 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PALI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for PALI is $23, which is 3384.8% higher than the current price. The consensus rating is "Buy".
Price Target | $23 |
Price Target Difference | 3384.8% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Stock Splits
The last stock split was on Apr 8, 2024. It was a backward split with a ratio of 1:15.
Last Split Date | Apr 8, 2024 |
Split Type | backward |
Split Ratio | 1:15 |
Scores
Altman Z-Score | -20.55 |
Piotroski F-Score | 3 |